News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
7,575 Results
Type
Article (389)
Company Profile (10)
Press Release (7176)
Section
Business (1795)
Deals (290)
Drug Delivery (1)
Drug Development (1870)
FDA (195)
Job Trends (362)
News (3950)
Policy (307)
Tag
2024 BioForest Digital (1)
2024 Biotech Bay Standard (1)
2024 Genetown Digital (1)
2024 Pharm Country Digital (1)
Academia (26)
Alliances (446)
ALS (6)
Alzheimer's disease (3)
Antibody-drug conjugate (ADC) (2)
Approvals (198)
Artificial intelligence (3)
Autoimmune disease (1)
Best Places to Work (379)
Biotechnology (10)
Bladder cancer (6)
Brain cancer (2)
Breast cancer (8)
Cancer (98)
Cardiovascular disease (3)
CAR-T (10)
Cell therapy (33)
Cervical cancer (2)
Clinical research (1521)
Collaboration (19)
Compensation (1)
COVID-19 (8)
CRISPR (11)
C-suite (6)
Cystic fibrosis (2)
Data (71)
Diagnostics (50)
Drug discovery (1)
Drug pricing (1)
Duchenne muscular dystrophy (1)
Earnings (716)
Events (1557)
Executive appointments (13)
FDA (232)
Featured Employer (2)
Funding (23)
Gene editing (27)
Gene therapy (28)
GLP-1 (6)
Government (49)
Healthcare (276)
Huntington's disease (1)
IgA nephropathy (1)
Indications (2)
Infectious disease (8)
Inflammatory bowel disease (1)
Intellectual property (3)
IPO (202)
IRA (1)
Job creations (8)
Layoffs (6)
Legal (21)
Liver cancer (6)
Lung cancer (19)
Lymphoma (6)
Manufacturing (2)
Medical device (31)
Medtech (31)
Mergers & acquisitions (96)
Multiple sclerosis (2)
Neurodegenerative disease (4)
Neuroscience (17)
NextGen: Class of 2025 (74)
Non-profit (40)
Northern California (89)
Opinion (3)
Ovarian cancer (1)
Pain (1)
Pancreatic cancer (5)
Parkinson's disease (3)
Partnered (1)
Patents (5)
Patient recruitment (6)
People (603)
Phase I (669)
Phase II (693)
Phase III (434)
Pipeline (40)
Policy (1)
Postmarket research (13)
Preclinical (200)
Press Release (1)
Prostate cancer (11)
Radiopharmaceuticals (4)
Rare diseases (20)
Real estate (20)
Regulatory (279)
Research institute (25)
Series A (4)
Series B (2)
Service/supplier (1)
Sickle cell disease (11)
Southern California (20)
Spinal muscular atrophy (5)
Startups (45)
United States (487)
Vaccines (4)
Venture capitalists (1)
Date
Today (9)
Last 7 days (12)
Last 30 days (45)
Last 365 days (746)
2025 (197)
2024 (841)
2023 (970)
2022 (1053)
2021 (1083)
2020 (782)
2019 (518)
2018 (356)
2017 (304)
2016 (298)
2015 (275)
2014 (195)
2013 (133)
2012 (133)
2011 (100)
2010 (57)
Location
Africa (1)
Alaska (1)
Arizona (1)
Asia (316)
Australia (45)
California (144)
Canada (30)
China (15)
Colorado (2)
Connecticut (3)
Delaware (6)
Europe (1364)
Florida (16)
Georgia (1)
Illinois (2)
India (1)
Japan (1)
Maryland (19)
Massachusetts (129)
Minnesota (5)
Missouri (1)
Nevada (1)
New Hampshire (1)
New Jersey (27)
New York (27)
North Carolina (24)
Northern California (89)
Ohio (5)
Pennsylvania (51)
South America (2)
South Carolina (1)
Southern California (20)
Texas (16)
Utah (2)
Virginia (2)
Washington State (13)
7,575 Results for "curative".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Tessera Therapeutics Receives Investment to Develop Curative In Vivo Genetic Treatment for Sickle Cell Disease
December 18, 2024
·
2 min read
Press Releases
Oxford Cancer Analytics Raises USD$11M in Series A Funding to Transform Early Lung Cancer Detection and Enable Curative Treatments
January 10, 2025
·
2 min read
Curative Biotechnology, Inc. Announces Nomination of Dr. Theresa Heah to Board of Directors.
Curative Biotechnology Inc. (OTC: CUBT) (“Curative Biotech” or the “Company”), a development-stage biomedical company focused on novel treatments for degenerative eye diseases today announced the nomination to its Board of Directors of Dr. Theresa Heah.
January 8, 2024
·
4 min read
Business
Curative Appoints Brandon Charles as New Chief Medical Officer
Dr. Brandon Charles has joined Curative as its new Chief Medical Officer.
November 28, 2023
·
3 min read
Press Releases
Kite Presents New Data Underscoring Curative Potential of Yescarta® in Relapsed/Refractory Large B-cell Lymphoma at ASH
December 9, 2024
·
19 min read
Business
Curative Biotechnology, Inc. Announces Nomination of Dr. Jeffrey Liebmann to Board of Directors
Curative Biotechnology Inc. today announced its nomination to its Board of Directors of Dr. Jeffrey Liebmann.
October 31, 2023
·
4 min read
Biotech Bay
Curative Insurance Company Adds GRAIL’s Galleri® Test to Member Benefits for Multi-Cancer Early Detection
Curative Insurance Company, a pioneering healthcare services company, and GRAIL, LLC, a healthcare company whose mission is to detect cancer early when it can be cured, today announced the availability of Galleri®, a multi-cancer early detection (MCED) screening test to eligible insurance plan members.
February 1, 2024
·
8 min read
BioMidwest
Curative Biotechnology, Inc. Files Patent on Ophthalmic Formulation
Curative Biotechnology Inc. announced that a Patent Cooperation Treaty application was duly filed in the U.S. Receiving Office on May 22, 2023, claiming priority to U.S. Provisional Application No. 63/345,759, filed May 25, 2022.
May 24, 2023
·
2 min read
Drug Development
Excision’s CRISPR-Based HIV Treatment Fails to Show Curative Potential in Early Study
Results from a Phase I study presented Friday at the ASGCT 2024 annual meeting showed that despite a good safety profile, Excision BioTherapeutics’ HIV gene editor failed to suppress viral activity.
May 13, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Long-Term Follow-Up Data Continue to Support Beti-Cel as a Potentially Curative Gene Therapy for β-Thalassemia Patients Who Require Regular Transfusions Through Achievement of Durable Transfusion Independence and Normal or Near-Normal Adult Hb Levels
December 9, 2024
·
11 min read
1 of 758
Next
